6 completed, 2 active not recruiting, 1 not yet recruiting, 1 recruiting. 10 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 10 | Completed 6, Active not recruiting 2, Not yet recruiting 1, Recruiting 1 |
| Phase 2 | 3 | Completed 2, Active not recruiting 1 |
Follow perflutren: new trials by email Literature Review of perflutren trials Research Report on perflutren
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Multiparametric Ultrasound for the Diagnosis of Clinically Significant Prostate Cancer ultiparametric Magnetic Resonance Imaging, Perflutren lipid microsphere, Transrectal Ultrasound - Prostate Carcinoma | Phase 3 | Not yet recruiting | Thomas Jefferson University | 300 | 2027-01-01 | 2026-11-16 |
| Noninvasive Subharmonic Aided Pressure Estimation of Portal Hypertension; Renewal SHAPE measurement (Sonazoid ultrasoud contrast agent), SHAPE measurement (Definity ultrasoud contrast agent) - Liver Diseases, Portal Hypertension | Phase 3 | Recruiting | Thomas Jefferson University | 660 | 2022-11-28 | 2026-10-02 |
| Prostate Cancer Diagnosis by Multiparametric Ultrasound (Wholemount) Perflutren Lipid Microspheres, Ultrasound - Prostate Carcinoma | Phase 3 | Active not recruiting | Thomas Jefferson University | 70 | 2022-06-15 | 2025-09-04 |
| SHAPE Neoadjuvant Chemotherapy Response Contrast-Enhanced Ultrasound, Perflutren Lipid Microspheres, Ultrasound - Anatomic Stage III Breast Cancer AJCC v8, Locally Advanced Breast Carcinoma | Phase 2 / Phase 3 | Active not recruiting | Kibo Nam | 122 | 2021-04-19 | 2026-09-23 |
| Diagnosing Compartment Syndrome With SHAPE vs Elastography Definity - Chronic Exertional Compartment Syndrome | Phase 2 / Phase 3 | Completed | Thomas Jefferson University | 15 | 2020-07-01 | 2023-12-12 |
| DEF-315 Better Accuracy in Ejection Fraction (EF) Assessment With DEFINITY DEFINITY® - Cardiac Disease | Phase 3 | Completed | Lantheus Medical Imaging | 160 | 2018-12-28 | 2021-01-28 |
| DEF-314 Better Accuracy in Ejection Fraction (EF) Assessment With DEFINITY DEFINITY - Cardiac Disease | Phase 3 | Completed | Lantheus Medical Imaging | 153 | 2018-10-24 | 2020-12-17 |
| Contrast-enhanced Ultrasound Evaluation of Chemoembolization Ultrasound contrast agent (Contrast-enhanced ultrasound), Logiq E9 Scanner (Contrast-enhanced ultrasound) - Hepatocellular Carcinoma, Chemoembolization, Therapeutic | Phase 3 | Completed | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 131 | 2016-04-01 | 2025-05-06 |
| Intravitreal tPA and C3F8 for the Treatment of Submacular Haemorrhage as a Complication of Neovascular AMD Ranibizumab, C3F8 Gas, tPA - Exudative Macular Degeneration, Retinal Hemorrhage | Phase 2 / Phase 3 | Completed | King's College Hospital NHS Trust | 55 | 2014-09-01 | 2020-07-14 |
| The Silicone Study Perfluoropropane, Sulfur Hexafluoride, Silicone Oil - Proliferative Vitreoretinopathy, Retinal Detachment | Phase 3 | Completed | National Eye Institute (NEI) | 1985-09-01 | 2005-06-24 |
Heart Diseases (2) · Prostatic Neoplasms (2) · Carcinoma, Hepatocellular (1) · Chronic Exertional Compartment Syndrome (1) · Hypertension, Portal (1) · Liver Diseases (1) · Macular Degeneration (1) · Retinal Detachment (1) · Retinal Hemorrhage (1) · Vitreoretinopathy, Proliferative (1) · Wet Macular Degeneration (1)
Thomas Jefferson University (4) · Lantheus Medical Imaging (2) · Kibo Nam (1) · King's College Hospital NHS Trust (1) · National Eye Institute (NEI) (1) · Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University (1)
United States (8) · Netherlands (1) · Switzerland (1) · United Kingdom (1)
Flemming Forsberg, PhD (3) · John Eisenbrey, PhD (1) · Kibo Nam, MD (1) · Timothy L Jackson, PhD,FRCOpht (1)
PMID 32408387, PMID 37847138, PMID 39418015
R01CA252311 (2), R01CA194307 (1), R01DK098526 (1), R37CA234428 (1)